{"id":"https://openalex.org/W2590734848","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","title":"Sequential monitoring and characterization of circulating tumor cells (CTCs) using the epic sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with recently approved therapeutics.","display_name":"Sequential monitoring and characterization of circulating tumor cells (CTCs) using the epic sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with recently approved therapeutics.","publication_year":2014,"publication_date":"2014-02-01","ids":{"openalex":"https://openalex.org/W2590734848","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","mag":"2590734848"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.4_suppl.78","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014912122","display_name":"Roberta Ferraldeschi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roberta Ferraldeschi","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047318865","display_name":"Rachel Krupa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Krupa","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112211811","display_name":"Jessica E. Louw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Louw","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090769437","display_name":"Eric Tucker","orcid":"https://orcid.org/0000-0003-3777-5961","observed_orcids":["https://orcid.org/0000-0003-3777-5961"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Tucker","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026568424","display_name":"Natalee Bales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalee Bales","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030938271","display_name":"Dena C. Marrinucci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dena Marrinucci","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040404659","display_name":"Penelope Flohr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Penelope Flohr","raw_affiliation_strings":["The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110102","display_name":"Ines Figueiredo","orcid":"https://orcid.org/0009-0007-7334-7362","observed_orcids":["https://orcid.org/0009-0007-7334-7362"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ines Figueiredo","raw_affiliation_strings":["The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028760417","display_name":"David Lorente","orcid":"https://orcid.org/0000-0001-7550-0657","observed_orcids":["https://orcid.org/0000-0001-7550-0657"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Lorente","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022442590","display_name":"Ryan Vance Dittamore","orcid":"https://orcid.org/0000-0003-2281-3232","observed_orcids":["https://orcid.org/0000-0003-2281-3232"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dittamore","raw_affiliation_strings":["Epic Sciences, Inc., La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, Inc., La Jolla, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann Sebastian De Bono","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gerhardt Attard","raw_affiliation_strings":["The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"4_suppl","first_page":"78","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.8579999804496765},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":1.0},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":1.0},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9200000166893005},{"id":"https://openalex.org/keywords/erg-rearrangement","display_name":"ERG rearrangement","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5139999985694885},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5389999747276306},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/cellsearch","display_name":"CellSearch","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.8793874979019165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.840469479560852},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.8373388051986694},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7907101511955261},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.7536418437957764},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.5782716274261475},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.565902590751648},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5003917217254639},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4599534571170807},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45801442861557007},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.4322197437286377},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.4184423089027405},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.37607696652412415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3401948809623718},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.24159613251686096},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.17774587869644165},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.17614829540252686},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.15178823471069336},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08477121591567993},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.4_suppl.78","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.78","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7200000286102295,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2432417581","https://openalex.org/W4251482248","https://openalex.org/W2337546820","https://openalex.org/W3028965462","https://openalex.org/W3155614938","https://openalex.org/W3134745828","https://openalex.org/W2517387251","https://openalex.org/W4386614885","https://openalex.org/W2791065691","https://openalex.org/W1897296552"],"abstract_inverted_index":{"78":[0],"Background:":[1],"The":[2],"enumeration":[3],"and":[4,19,41,46,52,92,102,110,112,129,147,214,252,312,326,338],"molecular":[5,313],"characterization":[6,314],"of":[7,16,21,122,182,217,235,266,276,281,297,315],"circulating":[8],"tumor":[9],"cells":[10,96],"(CTCs)":[11],"may":[12],"allow":[13],"sequential":[14,56],"evaluation":[15],"drug-induced":[17,328],"changes":[18,263,329,332],"mechanisms":[20],"drug":[22],"resistance":[23],"that":[24],"cannot":[25],"be":[26],"practically":[27],"performed":[28],"by":[29,115,132],"tissue":[30],"biopsies.":[31],"Methods:":[32],"We":[33],"utilized":[34],"the":[35,142,189,318],"Epic":[36,222,308,319],"Sciences":[37,320],"platform":[38,321],"to":[39,85,88,104,198,209,225,288,304,347],"identify":[40],"characterize":[42],"traditional":[43],"CTCs":[44,51,118,134,316],"(CK-CD45+)":[45],"other":[47],"CTC":[48,113,192,223,243,267,334],"subpopulations":[49],"(CK-CD45-":[50],"small":[53],"CTCs)":[54],"in":[55,241,249,264,333,355],"samples":[57],"obtained":[58],"from":[59,119,135,165],"metastatic":[60],"castration-resistant":[61],"prostate":[62],"cancer":[63],"(mCRPC)":[64],"patients":[65,123],"(pts)":[66],"receiving":[67],"abiraterone":[68],"acetate":[69],"(AA),":[70],"enzalutamide":[71],"(E),":[72],"or":[73,207,286,302],"cabazitaxel":[74],"(C).":[75],"Peripheral":[76],"blood":[77,138],"was":[78,194,271],"collected":[79,140],"pre-treatment,":[80],"during":[81,258,322],"treatment":[82,259,323],"(at":[83],"1":[84],"4":[86],"weeks,":[87],"evaluate":[89],"pharmacodynamics":[90],"effects)":[91],"at":[93,141],"progression.":[94],"Nucleated":[95],"were":[97,124,145,155,256],"plated":[98],"onto":[99],"glass":[100],"slides":[101],"subjected":[103],"immunofluorescence":[105],"staining":[106],"for":[107,126,157,273],"CK,":[108],"CD45,":[109],"AR,":[111],"identification":[114],"fluorescent":[116],"scanners.":[117],"a":[120,136,239],"subset":[121],"tested":[125],"PTEN":[127],"loss":[128],"ERG":[130],"rearrangements":[131],"FISH.":[133],"second":[137],"sample":[139],"same":[143],"time":[144],"captured":[146,291],"enumerated":[148],"using":[149,292,307],"CellSearch":[150,269],"(Veridex).":[151],"Fresh":[152],"CRPC":[153],"biopsies":[154],"available":[156,164,272],"9":[158],"pts.":[159,278],"Results:":[160],"Initial":[161],"results":[162],"are":[163],"24":[166,183,277],"mCRPC":[167],"pts":[168,170,203,219,237],"(16":[169],"treated":[171,185],"with":[172,175,178,186,231,299,331],"AA;":[173],"four":[174,177],"E;":[176],"C;":[179],"17":[180],"out":[181,216,234,275,280,296],"previously":[184],"docetaxel).":[187],"Pre-treatment,":[188],"median":[190],"CK+CD45-":[191,211,229,242],"count":[193,244,265,270],"3.5":[195],"(range":[196],"0":[197],"98)":[199],"cells/mL":[200],"blood.":[201],"Eleven":[202],"had":[204,220,238,283],"more":[205,284,300],"than":[206,227,246,285,301],"equal":[208,287,303],"5":[210,215,228],"CTCs/mL":[212,230],"pre-treatment":[213],"11":[218,236],"an":[221],"conversion":[224],"less":[226],"treatment.":[232],"8":[233],"decline":[240],"greater":[245],"30%.":[247],"Changes":[248],"AR":[250,253,336,339],"expression":[251,337],"subcellular":[254,340],"localization":[255],"observed":[257],"as":[260,262,351],"well":[261],"subpopulations.":[268],"22":[274,282],"Twelve":[279],"five":[289,305],"CTCs/7.5mls":[290],"CellSearch,":[293],"including":[294],"7":[295],"12":[298],"CTCs/ml":[306],"platform.":[309],"Conclusions:":[310],"Enumeration":[311],"on":[317],"is":[324],"feasible":[325],"demonstrates":[327],"associated":[330],"count,":[335],"localization.":[341],"These":[342],"assays":[343],"warrant":[344],"further":[345],"studies":[346],"validate":[348],"their":[349],"role":[350],"clinically":[352],"useful":[353],"biomarkers":[354],"mCRPC.":[356]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-03-03T00:00:00"}